EP1180022A4 - Elaboration d'un produit pharmaceutique en vrac uniformement dissout - Google Patents

Elaboration d'un produit pharmaceutique en vrac uniformement dissout

Info

Publication number
EP1180022A4
EP1180022A4 EP99927538A EP99927538A EP1180022A4 EP 1180022 A4 EP1180022 A4 EP 1180022A4 EP 99927538 A EP99927538 A EP 99927538A EP 99927538 A EP99927538 A EP 99927538A EP 1180022 A4 EP1180022 A4 EP 1180022A4
Authority
EP
European Patent Office
Prior art keywords
bulk material
preparing pharmaceutical
uniform dissolution
pharmaceutical bulk
dissolution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99927538A
Other languages
German (de)
English (en)
Other versions
EP1180022A1 (fr
Inventor
Frank Brown Jr
Robert Alan Forbes
Arlette Faye Kreager
Michael Vincent Mullen
Gregory Alan Stephenson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of EP1180022A1 publication Critical patent/EP1180022A1/fr
Publication of EP1180022A4 publication Critical patent/EP1180022A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP99927538A 1999-05-14 1999-06-15 Elaboration d'un produit pharmaceutique en vrac uniformement dissout Withdrawn EP1180022A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13421599P 1999-05-14 1999-05-14
US134215P 1999-05-14
PCT/US1999/013481 WO2000069417A1 (fr) 1999-05-14 1999-06-15 Elaboration d'un produit pharmaceutique en vrac uniformement dissout

Publications (2)

Publication Number Publication Date
EP1180022A1 EP1180022A1 (fr) 2002-02-20
EP1180022A4 true EP1180022A4 (fr) 2004-01-07

Family

ID=22462288

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99927538A Withdrawn EP1180022A4 (fr) 1999-05-14 1999-06-15 Elaboration d'un produit pharmaceutique en vrac uniformement dissout

Country Status (3)

Country Link
EP (1) EP1180022A4 (fr)
AU (1) AU4441899A (fr)
WO (1) WO2000069417A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6468976B1 (en) * 2001-09-10 2002-10-22 Astrazeneca Ab Monohydrate lisinopril
US6465615B1 (en) * 2001-09-10 2002-10-15 Astrazeneca Ab Monohydrate lisinopril

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4713247A (en) * 1983-06-15 1987-12-15 Shionogi & Co., Ltd. Long-acting formulation of cefaclor
US4968508A (en) * 1987-02-27 1990-11-06 Eli Lilly And Company Sustained release matrix
US5516531A (en) * 1987-01-29 1996-05-14 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
US5837292A (en) * 1996-07-03 1998-11-17 Yamanouchi Europe B.V. Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1251999B (it) * 1991-11-11 1995-05-27 Opos Biochimica Srl Forma cristallina di un antibiotico cefalosporinico

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4713247A (en) * 1983-06-15 1987-12-15 Shionogi & Co., Ltd. Long-acting formulation of cefaclor
US5516531A (en) * 1987-01-29 1996-05-14 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
US4968508A (en) * 1987-02-27 1990-11-06 Eli Lilly And Company Sustained release matrix
US5837292A (en) * 1996-07-03 1998-11-17 Yamanouchi Europe B.V. Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHOW ALBERT H L ET AL: "Parameters affecting in-liquid drying microencapsulation and release rate of cefaclor.", INTERNATIONAL JOURNAL OF PHARMACEUTICS (AMSTERDAM), vol. 172, no. 1-2, 15 October 1998 (1998-10-15), pages 113 - 125, XP001147521, ISSN: 0378-5173 *
See also references of WO0069417A1 *

Also Published As

Publication number Publication date
WO2000069417A1 (fr) 2000-11-23
EP1180022A1 (fr) 2002-02-20
AU4441899A (en) 2000-12-05

Similar Documents

Publication Publication Date Title
HUP0203198A3 (en) Pharmaceutical composition comprising a tramadol material and an anticonvulsant drug, process for its preparation and its use
HK1043087A1 (en) Soluble material and process for three-dimensionalmodeling
HUP0201376A2 (en) Thiazoloderivatives and pharmaceutical compositions containing them and process for preparation the compounds
AU143343S (en) A container for example for a pharmaceutical substance
GB2367545B (en) Apparatus for conveying loose material
HUP0203278A3 (en) Apparatus and process for preparing crystalline particles
HK1046236A1 (zh) 迅速溶解的劑量形式及其生產方法
HUP0100431A3 (en) Adamantana derivatives, pharmaceutical compositions comprising them and process for preparing them
HUP0000748A3 (en) 4-phenyl-piridine derivatives, process for producing them and pharmaceutical compositions containing them
HK1046219B (zh) 製備充氣冷凍產品
IL149618A0 (en) Pharmaceutical compositions comprising thiazolidinedione and process for preparation thereof
HUP0105108A3 (en) Amide compounds, process for their preparation and pharmaceutical compositions containing them
HUP0201402A3 (en) Bis-sulfonamides, process for their preparation and pharmaceutical compositions containing them
EG22337A (en) Process for preparing novel pharmaceutical compounds
HUP0100336A3 (en) Vla-4 antagonists, pharmaceutical compositions comprising them and process for preparing them
HUP0204069A3 (en) Novel processes for making- and a new crystalline form of- leflunomide and pharmaceutical composition containing it
HUP9801950A3 (en) 2-(arylphenyl-amino)-imidazoline derivatives, process for producing them and pharmaceutical compositions containing them
HUP0201785A3 (en) Dihydrobenzodiazepins, process for producing them, their use and pharmaceutical compositions containing them
HUP0105479A3 (en) Betha-alanine derivatives, process for producing them and pharmaceutical compositions containing them
HUP0202322A3 (en) A substantially crystalline form of melagatran, process for obtaining it, pharmaceutical composition containing thereof and its use
IL131205A0 (en) Process for preparing pharmaceutical compounds
EP1180022A4 (fr) Elaboration d'un produit pharmaceutique en vrac uniformement dissout
HUP0200003A2 (en) Tetrahydrothiopyran-o-fluorinated phenylcarbamate derivatives and process for their preparation
HUP0201916A2 (en) Ethanesulfonyl-piperidine derivatives, process for producing them and pharmaceutical compositions containing them
HUP0200376A3 (en) Thiaoloindolinone compounds, process for their preparation and pharmaceutical composions containing them and their use

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20011214

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61K 31/546 B

Ipc: 7A 61K 9/16 B

Ipc: 7A 61K 9/48 A

A4 Supplementary search report drawn up and despatched

Effective date: 20031110

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20060103